Market Overview:
The global COPD devices market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of COPD, rising geriatric population, and technological advancements in COPD devices. Based on type, the global COPD devices market is segmented into nebulizers and inhalers. Inhalers are further sub-segmented into metered dose inhalers (MDIs) and dry powder inhalers (DPIs). Nebulizers are further sub-segmented into compressor nebulizers and ultrasonic nebulizers. Based on application, the global COPD devices market is segmented into hospitals, clinics, and home care. Geographically, the global COPD devices market is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa . North America dominates the global Copd Devices Market due to high prevalence of chronic obstructive pulmonary disease (COPD), increasing awareness about early diagnosis & treatment options for respiratory diseases among healthcare professionals & patients,,& technological advancements in medical device industry.
Product Definition:
COPD Devices are devices that are used to help people with COPD breathe better. They include things like inhalers, nebulizers, and oxygen tanks. COPD Devices help people with COPD get the air they need to breathe easier and stay healthy.
Nebulizers:
Nebulizers are devices that produce and project a series of high-pressure airflows, which are used to treat breathing disorders such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. Nebulizers come in different types with different capabilities such as powered nebulizer, unpowered nebulizer, ultrasonic nebulizer and humidifier among others. The type of device to be used depends on the severity of the disorder.
Inhalers:
Inhalers are devices that are used to inhale medications into the lungs. They can be powered by batteries or directly connected to a machine that pumps air into them. The most common types of inhalers available in the market include nebulizers and metered dose inhalers (MDI).
Application Insights:
Based on the application, the market is segmented into hospitals, clinics and home care. The hospital segment dominated the COPD devices market in 2017 owing to a large patient base suffering from chronic bronchitis and emphysema. According to estimates by Global Burden of Disease Study, an annual average of 1.3 million deaths occur due to COPD globally; out of which 90% are caused by smoking related diseases.
The clinic/medical device segment is expected to witness lucrative growth over forecast period owing to increasing prevalence of COPD coupled with rising awareness among individuals regarding availability of advanced medical devices for treatment at clinics or hospitals instead at homes or other remote locations where patients may have limited access to healthcare facilities due primarily either geographic location or financial constraints that prevent them from traveling long distances for seeking medical attention resulting in under utilization rates leading ultimately in high demand thereby driving growth rate over forecast period.
Regional Analysis:
North America dominated the global COPD devices market in 2017. This can be attributed to increasing awareness about early diagnosis, high disease prevalence, and availability of highly effective and sophisticated treatment procedures for COPD. Moreover, presence of well-established healthcare facilities and favorable reimbursement policies are some other factors contributing toward the growth of this market in North America.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising geriatric population along with an increase in lifestyle-related diseases such as cardiac disorders that result into chronic respiratory problems such as asthma or COPD. In addition, growing medical tourism industry due to low cost treatments offered by local hospitals & clinics is also one factor anticipated to boost demand for these devices in this region during the forecast period from 2018 - 2030 (USD Million).
Growth Factors:
- Increasing prevalence of COPD: The global prevalence of COPD is expected to increase from approximately 210 million in 2015 to nearly 250 million by 2025. This is due to the aging population and rising smoking rates in developing countries.
- Advances in technology: There have been significant advances in the diagnosis and treatment of COPD over the past decade, with new devices and therapies becoming available. These advances are likely to continue, providing patients with more options for managing their condition.
- Growing awareness of COPD: There is increasing awareness of COPD among both patients and healthcare professionals, which is helping to drive demand for devices and treatments.
- Rising healthcare expenditure: Governments around the world are investing more money into healthcare, which is benefiting the market for COPD devices.
Scope Of The Report
Report Attributes
Report Details
Report Title
COPD Devices Market Research Report
By Type
Nebulizers, Inhalers
By Application
Hospitals, Clinics, Home Care
By Companies
PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, PARI GmbH, GF Health Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global COPD Devices Market Report Segments:
The global COPD Devices market is segmented on the basis of:
Types
Nebulizers, Inhalers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- PARI GmbH
- Omron
- Drive DeVilbiss Healthcare
- Philips Respironics
- Yuwell
- Leyi
- Folee
- Medel S.p.A
- Briggs Healthcare
- 3A Health Care
- PARI GmbH
- GF Health Products
Highlights of The COPD Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nebulizers
- Inhalers
- By Application:
- Hospitals
- Clinics
- Home Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the COPD Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A COPD device is a medical device that helps people with COPD breathe better. These devices can help people to improve their breathing by helping them to take deeper breaths, and they can also help people to avoid getting too much air into their lungs.
Some of the major players in the copd devices market are PARI GmbH, Omron, Drive DeVilbiss Healthcare, Philips Respironics, Yuwell, Leyi, Folee, Medel S.p.A, Briggs Healthcare, 3A Health Care, PARI GmbH, GF Health Products.
The copd devices market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 COPD Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 COPD Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 COPD Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the COPD Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global COPD Devices Market Size & Forecast, 2018-2028
4.5.1 COPD Devices Market Size and Y-o-Y Growth
4.5.2 COPD Devices Market Absolute $ Opportunity
Chapter 5 Global COPD Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 COPD Devices Market Size Forecast by Type
5.2.1 Nebulizers
5.2.2 Inhalers
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global COPD Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 COPD Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Home Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global COPD Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 COPD Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America COPD Devices Analysis and Forecast
9.1 Introduction
9.2 North America COPD Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America COPD Devices Market Size Forecast by Type
9.6.1 Nebulizers
9.6.2 Inhalers
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America COPD Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Home Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe COPD Devices Analysis and Forecast
10.1 Introduction
10.2 Europe COPD Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe COPD Devices Market Size Forecast by Type
10.6.1 Nebulizers
10.6.2 Inhalers
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe COPD Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Home Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific COPD Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific COPD Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific COPD Devices Market Size Forecast by Type
11.6.1 Nebulizers
11.6.2 Inhalers
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific COPD Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Home Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America COPD Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America COPD Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America COPD Devices Market Size Forecast by Type
12.6.1 Nebulizers
12.6.2 Inhalers
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America COPD Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Home Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) COPD Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) COPD Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) COPD Devices Market Size Forecast by Type
13.6.1 Nebulizers
13.6.2 Inhalers
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) COPD Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Home Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 COPD Devices Market: Competitive Dashboard
14.2 Global COPD Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 PARI GmbH
14.3.2 Omron
14.3.3 Drive DeVilbiss Healthcare
14.3.4 Philips Respironics
14.3.5 Yuwell
14.3.6 Leyi
14.3.7 Folee
14.3.8 Medel S.p.A
14.3.9 Briggs Healthcare
14.3.10 3A Health Care
14.3.11 PARI GmbH
14.3.12 GF Health Products
